Henderson Michael Thomas

Spyre Therapeutics, Inc. · Director

Henderson Michael Thomas is listed in filings as Director at Spyre Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 23, 2026, including sale activity. Recent filings connect the profile to Spyre Therapeutics, Inc. (SYRE) and Apogee Therapeutics, Inc. (APGE). The current snapshot covers public activity from Aug 9, 2024 to Jun 23, 2026. Reported amounts are shown as $2.0M to $1.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceLast Price
Spyre Therapeutics, Inc.SYRE$1M19.3k sharesSellMay 8, 2026$75.35$102.70
Spyre Therapeutics, Inc.SYRE$2M24.8k sharesSellMay 8, 2026$74.76$102.70
Spyre Therapeutics, Inc.SYRE$2M33.5k sharesSellMay 8, 2026$73.72$102.70
Spyre Therapeutics, Inc.SYRE$174k2.4k sharesSellMay 8, 2026$72.57$102.70
Apogee Therapeutics, Inc.APGE$4.2k100 sharesSellAug 7, 2024$42.17$134.08
Apogee Therapeutics, Inc.APGE$318k7.7k sharesSellAug 7, 2024$41.52$134.08
Apogee Therapeutics, Inc.APGE$1M32.2k sharesSellAug 7, 2024$40.40$134.08
Apogee Therapeutics, Inc.APGE$693k14.4k sharesSellSep 4, 2024$48.23$134.08
Apogee Therapeutics, Inc.APGE$1M25.6k sharesSellSep 4, 2024$47.28$134.08
Apogee Therapeutics, Inc.APGE$551k9.7k sharesSellOct 2, 2024$56.74$134.08
Apogee Therapeutics, Inc.APGE$2M30.3k sharesSellOct 2, 2024$56.07$134.08
Apogee Therapeutics, Inc.APGE$60k1k sharesSellNov 6, 2024$59.94$134.08
Apogee Therapeutics, Inc.APGE$828k14k sharesSellNov 6, 2024$59.17$134.08
Apogee Therapeutics, Inc.APGE$79k1.7k sharesSellDec 4, 2024$47.19$134.08
Apogee Therapeutics, Inc.APGE$620k13.3k sharesSellDec 4, 2024$46.50$134.08
Apogee Therapeutics, Inc.APGE$142k2.9k sharesSellJan 8, 2025$49.38$134.08
Apogee Therapeutics, Inc.APGE$591k12.1k sharesSellJan 8, 2025$48.72$134.08
Apogee Therapeutics, Inc.APGE$609k15k sharesSellFeb 5, 2025$40.58$134.08
Apogee Therapeutics, Inc.APGE$82k2.7k sharesSellMar 5, 2025$30.62$134.08
Apogee Therapeutics, Inc.APGE$220k7.3k sharesSellMar 5, 2025$29.98$134.08
Apogee Therapeutics, Inc.APGE$6.5k100 sharesSellNov 13, 2025$64.52$134.08
Apogee Therapeutics, Inc.APGE$114k1.8k sharesSellNov 13, 2025$63.89$134.08
Apogee Therapeutics, Inc.APGE$933k14.8k sharesSellNov 13, 2025$63.14$134.08
Apogee Therapeutics, Inc.APGE$207k3.3k sharesSellNov 13, 2025$61.93$134.08
Apogee Therapeutics, Inc.APGE$3M40k sharesSellDec 4, 2025$75.01$134.08
Apogee Therapeutics, Inc.APGE$43k560 sharesSellDec 10, 2025$76.58$134.08
Apogee Therapeutics, Inc.APGE$758k10k sharesSellDec 10, 2025$75.79$134.08
Apogee Therapeutics, Inc.APGE$706k9.4k sharesSellDec 10, 2025$74.88$134.08
Apogee Therapeutics, Inc.APGE$39k470 sharesSellJan 14, 2026$83.79$134.08
Apogee Therapeutics, Inc.APGE$448k5.4k sharesSellJan 14, 2026$83.16$134.08
Apogee Therapeutics, Inc.APGE$153k1.9k sharesSellJan 14, 2026$82.41$134.08
Apogee Therapeutics, Inc.APGE$192k2.4k sharesSellJan 14, 2026$81.00$134.08
Apogee Therapeutics, Inc.APGE$677k8.5k sharesSellJan 14, 2026$79.82$134.08
Apogee Therapeutics, Inc.APGE$113k1.4k sharesSellJan 14, 2026$78.64$134.08
Apogee Therapeutics, Inc.APGE$62k955 sharesSellFeb 11, 2026$64.99$134.08
Apogee Therapeutics, Inc.APGE$481k7.6k sharesSellFeb 11, 2026$63.73$134.08
Apogee Therapeutics, Inc.APGE$724k11.5k sharesSellFeb 11, 2026$62.96$134.08
Apogee Therapeutics, Inc.APGE$259k3.4k sharesSellMar 11, 2026$75.86$134.08
Apogee Therapeutics, Inc.APGE$615k8.2k sharesSellMar 11, 2026$74.83$134.08
Apogee Therapeutics, Inc.APGE$621k8.4k sharesSellMar 11, 2026$74.29$134.08
Apogee Therapeutics, Inc.APGE$17k200 sharesSellApr 8, 2026$85.00$134.08
Apogee Therapeutics, Inc.APGE$167k2k sharesSellApr 8, 2026$83.26$134.08
Apogee Therapeutics, Inc.APGE$1M17.8k sharesSellApr 8, 2026$82.48$134.08
Apogee Therapeutics, Inc.APGE$111k1.3k sharesSellMay 13, 2026$82.58$134.08
Apogee Therapeutics, Inc.APGE$2M18.7k sharesSellMay 13, 2026$82.05$134.08